Search Results - Fatma Gossiel

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Bone Turnover Markers: Basic Biology to Clinical Applications

    Bone Turnover Markers: Basic Biology to Clinical Applications by Marian Schini, Tatiane Vilaça, Fatma Gossiel, Syazrah Salam, Richard Eastell

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy

    Diagnostic Accuracy of Biomarkers and Imaging for Bone Turnover in Renal Osteodystrophy by Syazrah Salam, Orla Gallagher, Fatma Gossiel, Margaret Paggiosi, Arif Khwaja, Richard Eastell

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?

    DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful? by Richard Eastell, Tom Pigott, Fatma Gossiel, K.E. Naylor, Jennifer Walsh, Nicola Peel

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Serum Retinoids and β-Carotene as Predictors of Hip and Other Fractures in Elderly Women

    Serum Retinoids and β-Carotene as Predictors of Hip and Other Fractures in Elderly Women by Margo E. Barker, Eugène McCloskey, Shikha Saha, Fatma Gossiel, D Charlesworth, Hilary J. Powers, Aubrey Blumsohn

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study

    Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study by K.E. Naylor, Richard Jacques, Margaret Paggiosi, Fatma Gossiel, Nicola Peel, Eugène McCloskey, Jennifer Walsh, Richard Eastell

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis

    Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis by K.E. Naylor, Eugène McCloskey, Richard Jacques, Nicola Peel, Margaret Paggiosi, Fatma Gossiel, Jennifer Walsh, Richard Eastell

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5

    Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5 by Morten Frost, Tom Andersen, Fatma Gossiel, Stinus Hansen, Jens Bollerslev, Wim Van Hul, Richard Eastell, Moustapha Kassem, Kim Brixen

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, placebo-controlled trial

    Changes in bone mineral density at 3 years in postmenopausal women receiving anastrozole and risedronate in the IBIS-II bone substudy: an international, double-blind, randomised, p... by Ivana Šestak, Shalini Singh, Jack Cuzick, Glen M. Blake, Rajesh Patel, Fatma Gossiel, Rob Coleman, Mitch Dowsett, John Forbes, Anthony Howell, Richard Eastell

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial

    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial by Janet E. Brown, Emma Rathbone, Samantha Hinsley, Walter M. Gregory, Fatma Gossiel, Helen Marshall, Roger Burkinshaw, Helen Shulver, Hasina Thandar, Gianfilippo Bertelli, Keane Maccon, Angela Bowman, Andrew M. Hanby, Richard H. Bell, David Cameron, Robert E. Coleman

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease

    Cortical-Bone Fragility — Insights from sFRP4 Deficiency in Pyle’s Disease by Pelin Özlem Şimşek‐Kiper, Hiroaki Saito, Francesca Gori, Sheila Unger, Eric Hesse, Kei Yamana, Riku Kiviranta, Nicolas Solban, Jeff Liu, Robert Brommage, Koray Boduroğlu, Luisa Bonafé, Belinda Campos‐Xavier, Esra Dikoglu, Richard Eastell, Fatma Gossiel, Keith Harshman, Gen Nishimura, Katta M. Girisha, Brian J. Stevenson, Hiroyuki Takita, Carlo Rivolta, Andrea Superti‐Furga, Roland Baron

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

    11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial by Nantia Othonos, Riccardo Pofi, Anastasia Arvaniti, Sarah White, Ilaria Bonaventura, Nikolaos Nikolaou, Ahmad Moolla, Thomas Marjot, Roland H. Stimson, André P. van Beek, Martijn van Faassen, Andrea M. Isidori, Elizabeth Bateman, Ross Sadler, Fredrik Karpe, Paul M. Stewart, Craig Webster, Joanne Duffy, Richard Eastell, Fatma Gossiel, Thomas Cornfield, Leanne Hodson, Katherine J. Escott, Andrew K. Whittaker, Ufuk Kirik, Ruth L. Coleman, Charles A.B. Scott, Joanne Milton, Olorunsola F. Agbaje, Rury R. Holman, Jeremy Tomlinson

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: